L-arginine improves endothelial function in newly diagnosed hypertensives  by Rosano, G.M.C. et al.
262A ABSTRACTS - Poster JACC February 1~)98 
(+)), With hlgh.n,~r~lqtion ultrasound, we measured the diameter of bnchial 
artertaa at boosting, during nacllve hypenmla (endothellum dependent va- 
sodllatatlon reused by Incnased flow), and after aubllnguel nitroglycerin (an 
endothellum.indepondent dllol~tion). 
R¢~lt~: Flow.medisled dllalion was observed in FH (-) gnup, but was 
slgnlflcantly Impaired or absent in FH (+) gnup (8,3 :t 1,9% and 6,1 :~ 
~,4%, reape(:fNely; P = 0,00237), Nllnglyeerln caused a similar vesedtlatlon 
in both groups (18,6 • 5,0% in FH (~) group and 17,2 ± 4,9% in FH (+) 
gnup; P = N$), Baseline vestal diameter, blood flow, and degree of reaclive 
hyparemla (Ooppiar estimated) ware similar i~ '~ .~1~1 gnupc, Thus andothellal 
dyMgn~tlon is already pro#ant In normotanslve ~d,lls with family hiMow of 
en~ntlal hYl~rtonwlon, 
Conclu~torl: This early endothelial dyMgnetlon might lead to the future 
development ot hypoftanslon, 
~ Abnormal  Capil lary Permeabil ity in 
Uncompl leMod Hypertensive 8ubloet8 and 
NormotlnalvQ Athoro|c lorot lo  Patients 
R, Peddnelll ~ , G, Dell'grog ~ , A., Conhle.1, V. DI Belle ~ , S, BandioellP, 
R, Navatesl ~, G, Panno °, ~Cltnica M~/i~, Italy; ~Ot~l/~fO/ogt~, Unlv~rait,'t el,
Pt~,/tory 
B l~,~nd:  Human endothelial function has been Mudied in several elinl. 
eal oondltiena, Including esaenltal hype~lenslon and ethemaelemllo vascular 
dlsaaoe, mainly by evaluating the raglonal vaaorelaxatlon indgoed by on. 
o'olhellum.~pendenl veaodllstom, Still, Incal vaaodilotafion mflacto the m, 
aponalveneas of an aftaflolar segment while scans information la ~velloble 
on the eapillaty network which contains room O! the endothelial OOlls~ 
M~Mriat ~ Mefhod~: (mean~ :~ SO); The Mtldy was performed in 12 Mild. 
medara~ Unoompltcated Eosantlal Hypertenalves (EH, ABPM.~4,,,; 148 t 
10/68 ~ 8 mmHg. age: 55 ± 0,g yra, BMh 20,6 ~ ~,8 Kgtm ~) and 18 nor- 
mot~nslv~ (ABPM~,~fi 116 ~: B/6B ¢ 9 mmHg) Patients With Athenaclorelie 
Peripheral V~oeular Disease (ATH. 57 ± 0,0 yn, BMI: ~5,4 ~ 0,2,2 Kg/m°), 
All subl~e ware melee, non diabolic, never treated or untreated for at least 
two weeks, 8 Normal Males (NOR, 59 ~ 11 ym, ABPM~.,,', 121 t 7/73 t 
4 mmHg, BMI: 25,4 ~t 0,~],2 Kg/m ~) wan the controls, Evaluation va0ablos 
wan 1, Tmnaooplllon/albumin escape rate (TERse, %/hr, the one.hour de- 
cline fate el Lv, ~Sl-albumtn), a moesun of maommolt~ctdar permeability of 
capillary andofhellum and 2, Forearm blood flow (FBF, v~nous plalhysmog- 
raphy) naponse (dmgroasellna ratio) to t,e, acetylchollna (ACH, 7,5, 15, 30 
t~g/mtn), ~n endothellum-dependonf vasndllator. Total cholesterol (ATH: 239 
33 vs EH: 181 * 24 & NOR: 206 .~.- 45 mg/dl) and trlglycertdes (ATH: 193 
100 vs EH: 121 :f 78 & NOR: 117 ~ 69 mg/dl) wore higher (p .  0.01) in 
ATH, 
Re~ufts: TER^cn was comparable between ATH and EH (10.3 t 2,8 vs 
10,4 ~ 3,2%/hr) and higher (p .: 0,004) than in NOR (7,1 t 1,5%/hr). Forearm 
vasodilofaGon to ACH (EH: 3,2 ~ 1.5, 5.1 ± 23, 6,9 ~- 2,4 vs NOR: 33 
1,8, 5,3 t 3.2, 6.5 ~ 2,3) was presented in EH and nduced in ATH (ACH: 
3,2 ~t f,6, 3.9 .f 1,5, 5 ± 1,9 p -~ 0.05 vs NOR), Individual TER~L, values 
and maximum vasndilatlng responses Io ACH wen unnlaled, 
ConChs/one: TER^~.e is abnormal in EH and normolenstve ATH indicating 
a systemic capillary dysfunction independent of BP levels, Independence of 
TER^Le tam ACH artonolor nsponslveness uggests that involvement of 
dlffennf mechanisms of dysb, lnction al the caplllan/and aderlolar level. 
~ Nitric Oxide-mediated Vasodl iet lon (tolerance) to 
Hypsrtsnelve Effects o f  Ethanol 
S,J, Hutchison, K, Sudhir, T.M. Chou, K. Chatte~ee, V.M, Figueredo. 
University of California. San Francisco. USA 
Background: Chronic heavy ethanol ingestion causes hypertension. 
Method: To measure changes in vascular reactivity induced by chronic 
ethanol, we studied aortae from co~trol nts and from rats fed 36% ethanol as 
drinking water for 1 year. Ring segments wen contracted with norepinephnne 
(NE), phenylephnne (Phe), and KCI. Following incubation with the nitdc oxide 
inhibitor *nitro-L-arginino methyl ester (L-NAME), or mechanical denudation 
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(DN), rings wen contracted again, Phe preconfracted nngs wen nlaxed by 
ecetylchollna (ACh) and nltnglyoortn (NTG). 
Results: Ethanol nd,oed maximal ¢ontnctlon to Phe (p ,,, 0.04) and to 
NE (p ,, 0,03), L-NAME andDNabollshed llfonnces in NE-indueed tenolon, 
Then was no dlffennoo in KCl.lnduood oonalr¢tion, Maximal ACh.leduced 
relaxation was greater for ethanol fed rats (p < 0,05, NTG.Induood relaxation 
was similar, Blood pressure was greater for othaool rats (p - 0,01). 
Cor¢luslona: Chnnlo high dose ethanol eauaao 1) hypellenalon, 2) r~ 
ducod edrenoceptor.medlatnd contra~ion that to eedotho l ium.d~t  
and 3) Increased andothallum-del~ndonl nlaxalton, increased endothelial 
nlfde o~(Ida may conMifute en edapttvo vaaeditalow m~hanlam Io chronic 
adnnaKIIQ eenlrally.mediated hypel~itaive affncts 01 ell~nel, 
• L-Arglnlno Improves Endothelial In Function 
Newly Diagnosed Hypurtunslvea 
GMC, Resaoo, G, Panina, E, CeKNoIani, F, LeonafdQ, F. Pet!tea, 
B, Eight@i, ~,L, Chiamhta Depaelment of C ,~m~ fsMum H San 
RMt~e~, Mrt~nc~Rc'~m~. tf hj 
Wa have shown that oral L.Arginine oupplementahon m(kCea blood pm.ssun 
In unheated hypertensives possibly by nstonnU endothelial functmn. In order 
to lest this hypothesis, w~ Mudied ltow.mediabed va~latmn of the brecht; 
often/(FMV) in 14 untasted hype ~nsive pts (mean age 56 * B yearn, 9 
women), Using high ~asotufton ultrasound, the diameter 01 the ~ 1  aflefy 
wag measured st rest, dunng reactive hypenmia (FMV) and in 1 ~  
to nitnglyoBnna, Alter baoaline evNmdion pts were raedomlsed Io 
either oral L,A~inine (~ g, Iris) or malching pla~'ebo lot I week accordm9 
to a case.over double.blind protocol Resting systolic blood pressure was 
stgnllicantly reclu~d by L.ArQlnine but net by plaoobo (165 ± 20 vs 148 :L 
18 mmHg, L.Arginine vs EhJoellne, p < 0.05; 164 :~ ,?2 vs 158 ,28  mmHg, 
Baseline vs Plaosbo, p =~ NS). FMV was not alfecled by idacebo admmls- 
tratton (1,7 :t 2,3% va, 2,1 ~l~ 2.6%. p = NS) while increased ,s~g~f¢anlly 
attar oral L.Argmine (1,8 ~ 2, I% ~rs. 5.4 t 2.8%. p .  0.051. No ddfennce in 
GTN-induCed vasoddation was noted alter either L.Argmine or Placebo (166 
:L 7,5%, 15,6 ~ 5,5%, 18,2 ± 6,7%), 
In conclusion L.Arginine restores impaired endothellum dependent vs. 
sedilahen in newly diagnosed ben:lading hypertensives. This after! may ex- 
plain the hvpotensive ffect el L-Arginine 
• Improved Endothelium-dependent Vasodilation 
After Blockade of Endothelln Receptors in 
Patients With Essential  Hypertension 
C. Can:lille, C.M. Kitcoyne. A.A. Quwumi, R.O. Cannon, IlL J.A. Panza 
NHLBI. Befhesda. MD~ uSA 
Hypedensivo patients (HTs) have impaired nltnc oxide (NO) actwUy, but 
the mechanism unUedymg thrs abnormality ts unknown. We have recently 
observed an incnased endothetin (ET) vasoconstnctor tone in HTs nlated 
to incnased production of the pepfide. In the pnseat study, we investigated 
whelhaT ti~e increased .=.1' actt~ty ot HTs could col,tribute to their ~mpatred 
NO-dependent vasedilator function. To this end. the vasodiletor nsponsec 
to acetylcholine (ACh; 7,5. 15. and 30 .g/mln), an endothelium-depeeden 
vasedilator, and sodium nitroprusside (SNP; 0.8, 1.6. and 3.2 I~g/min), an 
exogenous NO donor, were assessed baton and alter nonselective blockade 
of ETa and ETa receptors by combined inlusion o1 BQ-123 (ETA blocker; 100 
nmol/min) and BQ-788 (ETa blocker; 50 nmol/min) for 60 rein in 6 HTs. 
Drags wen infused into the bnchial aden/ and forearm bloOd flow (FBF) 
was measured by strain-gauge plethysmography. The increases in FBF from 
baseline induced by the 3 doses of ACh were significantly potentiated by 
nonselective blockade of ET receptors (0.47 ± 0.21 [mean ± SEMi. 2.73 
2.08, and 4,71 i 2.48 mUmin/dL before vs 3.38 ± 1.41, 6.06 ± 2.56. 
and 8.67 • 3.0G mLJmin/dL, after ET antagonism; P = 0,01) In contrast, ET 
receptor blockade did not signilicantly modity vascular responsiveness to 
the 3 doses of SNP (2.85 ± 0.95, 4.76 ± 1.47. and 7.18 ~: 2.27 mL/min/dL 
before vs 3,28 ± 1.01, 4.94 ~ 1.48, and 6.5 ~ 1.84 mL/min/dL after ET 
antagonism; P = 0.97). These findings indicate th.lt endothelial vasodilator 
function in HTs improves alter blockade of ET receptors, suggesting that 
an increased ET activity may be involved in the pathophysiology of their 
endothelial dysfunction. 
